Pricing
Login
Home
Charts
Search
Watchlist
Products

Curis Lifesciences Ltd

CURIS
₹158.00-4.24%20 Nov 2026
Reports
Pharma CRAMS

Curis Lifesciences Ltd

CURIS
₹158.00
-4.24%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹128Cr
Close
Close Price
₹158.00
Industry
Industry
Pharma CRAMS
PE
Price To Earnings
17.34
PS
Price To Sales
1.83
Revenue
Revenue
₹70Cr
Rev Gr TTM
Revenue Growth TTM
—
PAT Gr TTM
PAT Growth TTM
—

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2025Mar 2026Sep 2026
Revenue
RevenueCr
283337
Growth YoY
Revenue Growth YoY%
32.7
Expenses
ExpensesCr
222831
Operating Profit
Operating ProfitCr
656
OPM
OPM%
21.515.716.6
Other Income
Other IncomeCr
000
Interest Expense
Interest ExpenseCr
011
Depreciation
DepreciationCr
000
PBT
PBTCr
656
Tax
TaxCr
122
PAT
PATCr
434
Growth YoY
PAT Growth YoY%
-1.4
NPM
NPM%
15.18.311.2
EPS
EPS₹
7.13.45.8
QuarterSep 2025Mar 2026Sep 2026
Revenue
RevenueCr
283337
Growth YoY
Revenue Growth YoY%
32.7
Expenses
ExpensesCr
222831
Operating Profit
Operating ProfitCr
656
OPM
OPM%
21.515.716.6
Other Income
Other IncomeCr
000
Interest Expense
Interest ExpenseCr
011
Depreciation
DepreciationCr
000
PBT
PBTCr
656
Tax
TaxCr
122
PAT
PATCr
434
Growth YoY
PAT Growth YoY%
-1.4
NPM
NPM%
15.18.311.2
EPS
EPS₹
7.13.45.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
243536506170
Growth
Revenue Growth%
49.10.541.320.6
Expenses
ExpensesCr
203227405058
Operating Profit
Operating ProfitCr
438111111
OPM
OPM%
15.19.223.721.418.416.2
Other Income
Other IncomeCr
000001
Interest Expense
Interest ExpenseCr
211111
Depreciation
DepreciationCr
111111
PBT
PBTCr
12791011
Tax
TaxCr
102333
PAT
PATCr
015677
Growth
PAT Growth%
151.0335.815.911.4
NPM
NPM%
2.13.515.112.411.49.8
EPS
EPS₹
10.39.1
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
243536506170
Growth
Revenue Growth%
49.10.541.320.6
Expenses
ExpensesCr
203227405058
Operating Profit
Operating ProfitCr
438111111
OPM
OPM%
15.19.223.721.418.416.2
Other Income
Other IncomeCr
000001
Interest Expense
Interest ExpenseCr
211111
Depreciation
DepreciationCr
111111
PBT
PBTCr
12791011
Tax
TaxCr
102333
PAT
PATCr
015677
Growth
PAT Growth%
151.0335.815.911.4
NPM
NPM%
2.13.515.112.411.49.8
EPS
EPS₹
10.39.1
Sales CAGR
1 Year21%
3 Years20%
5 Years-
TTM-
EBITDA CAGR
1 Year4%
3 Years51%
5 Years-
TTM-
PAT CAGR
1 Year11%
3 Years78%
5 Years-
TTM-
Avg. ROCE
1 Year0%
3 Years-
5 Years-
TTM0%
CFO / EBITDA
1 Year-148%
3 Years-
5 Years-
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2026Sep 2026
Equity Capital
Equity CapitalCr
808808
Reserves
ReservesCr
3,9274,341
Current Liabilities
Current LiabilitiesCr
Non Current Liabilities
Non Current LiabilitiesCr
Total Liabilities
Total LiabilitiesCr
8,1528,398
Current Assets
Current AssetsCr
Non Current Assets
Non Current AssetsCr
Total Assets
Total AssetsCr
8,1528,398
Financial YearMar 2026Sep 2026
Equity Capital
Equity CapitalCr
808808
Reserves
ReservesCr
3,9274,341
Current Liabilities
Current LiabilitiesCr
Non Current Liabilities
Non Current LiabilitiesCr
Total Liabilities
Total LiabilitiesCr
8,1528,398
Current Assets
Current AssetsCr
Non Current Assets
Non Current AssetsCr
Total Assets
Total AssetsCr
8,1528,398

Cash Flow

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2026
Operating Cash Flow
Operating Cash FlowCr
530-16
Investing Cash Flow
Investing Cash FlowCr
0-10-2
Financing Cash Flow
Financing Cash FlowCr
-5-3021
Net Cash Flow
Net Cash FlowCr
0003
Free Cash Flow
Free Cash FlowCr
CFO To PAT
CFO To PAT%
1,010.2272.45.2-237.3
CFO To EBITDA
CFO To EBITDA%
138.3102.83.3-147.5
Financial YearMar 2022Mar 2023Mar 2024Mar 2026
Operating Cash Flow
Operating Cash FlowCr
530-16
Investing Cash Flow
Investing Cash FlowCr
0-10-2
Financing Cash Flow
Financing Cash FlowCr
-5-3021
Net Cash Flow
Net Cash FlowCr
0003
Free Cash Flow
Free Cash FlowCr
CFO To PAT
CFO To PAT%
1,010.2272.45.2-237.3
CFO To EBITDA
CFO To EBITDA%
138.3102.83.3-147.5

Ratios

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
75128
Price To Earnings
Price To Earnings
10.917.3
Price To Sales
Price To Sales
1.21.8
Price To Book
Price To Book
0.00.0
EV To EBITDA
EV To EBITDA
172.3174.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
OPM
OPM%
15.19.223.721.418.416.2
NPM
NPM%
2.13.515.112.411.49.8
ROCE
ROCE%
0.20.2
ROE
ROE%
0.10.1
ROA
ROA%
0.10.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
75128
Price To Earnings
Price To Earnings
10.917.3
Price To Sales
Price To Sales
1.21.8
Price To Book
Price To Book
0.00.0
EV To EBITDA
EV To EBITDA
172.3174.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
OPM
OPM%
15.19.223.721.418.416.2
NPM
NPM%
2.13.515.112.411.49.8
ROCE
ROCE%
0.20.2
ROE
ROE%
0.10.1
ROA
ROA%
0.10.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr1,8122301491281239080
Close PriceClose₹115.57207.00135.00158.0057.0868.5152.75
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE17.5417.2617.3429.6626.24
Price To SalesPS0.662.281.091.834.580.931.23
RevenueRevenueCr2,75610113770279765
Revenue Growth TTMRev Gr TTM%-0.1%22.3%54.7%-1.4%114.4%
PAT Growth TTMPAT Gr TTM%-184.9%44.5%-3.4%51.4%410.3%
Market CapitalizationMkt CapCr1,8122301491281239080
Close PriceClose₹115.57207.00135.00158.0057.0868.5152.75
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE17.5417.2617.3429.6626.24
Price To SalesPS0.662.281.091.834.580.931.23
RevenueRevenueCr2,75610113770279765
Revenue Growth TTMRev Gr TTM%-0.1%22.3%54.7%-1.4%114.4%
PAT Growth TTMPAT Gr TTM%-184.9%44.5%-3.4%51.4%410.3%
Annual Reports
FY2026
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Load More
Interviews